HealthTap, a health technology company serving millions worldwide with its Health Operating System (HOPES™) powered by a network of 108,000 doctors and Artificial Intelligence, released a report today that revealed that compassion is more important than cost to patients (and doctors) when ranking doctors. In a climate where cost and access are often cited as key priorities among healthcare consumers and providers, this report indicates that despite rising healthcare costs and long wait times, both patients and doctors rank compassion as the most important element in healthcare today. In this survey on the role of compassion in medicine, 85% of patients reported that compassion was very important to them, whereas only 31% of respondents cited cost as being very important to them when making a healthcare decision. In comparison, wait time, which is often referenced as a key pain point for patients, only ranked at 48% in terms of being a very important factor in healthcare satisfaction. Most intriguing of all were the answers from the doctor respondents. 89% of doctors reported that compassion was a very important part of delivering the best care. This trumps even the importance doctors place on education and scholarly up-to-date command of medical knowledge (86%). In fact, 94% of the doctor respondents stated that compassionate makes their patients more likely to follow their advice, thus demonstrably improving health outcomes. “‘Compassion’ isn’t a word that you hear very often in Silicon Valley, but this survey proves that it’s the most important principle in healthcare,” said HealthTap Founder and CEO Ron Gutman. “The greater the role that technology and artificial intelligence play in healthcare, the greater the responsibility that we and other leading technologists have to build machines that value compassion just as much as doctors and patients do. We take that responsibility very seriously, and we have since the day I founded HealthTap in 2010. By teaching our technology how to practice and learn empathy, and by educating our employees and other stakeholders about the pivotal role compassion has in delivering the best health and care, we’re building a sustainable foundation to enable humans and machines to work in tandem to efficiently help billions everywhere live healthier, happier, and longer lives. That’s why compassion is the heart of our technology.” FULL SURVEY RESULTS:
READ THE OP-ED FROM HEALTHTAP’S CEO:
https://www.healthtap.com/goto/compassion_op_ed
WATCH A VIDEO OF PATIENT STORIES:
https://www.healthtap.com/goto/compassion_video
ACCESS THE PRESS KIT:
https://www.healthtap.com/goto/compassion_presskit
About HealthTap HealthTap is the world's first Global Health Practice, delivering immediate healthcare, 24/7, from Query-to-Cure. HealthTap connects hundreds of millions of people in 174 countries via video, voice, and text chat on any mobile device or personal computer with health advice from a Medical Expert Network of more than 108,000 doctors across 147 specialties. HealthTap's proprietary Health Operating System (HOPES™) and proprietary, Artificial-Intelligence triaging technology (Dr. A.I.™) enable hospital systems, insurance companies, employers and governments to deliver the right care at the right time at the right price. HOPES is now powering the HealthTap Cloud™, a first-of-its-kind virtual cloud dedicated to healthcare and created for interoperability and ease of integration. Our mission is to help people live healthier,
happier
, longer lives.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.